Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 28, Pages E6428-E6436
Publisher
Proceedings of the National Academy of Sciences
Online
2018-06-26
DOI
10.1073/pnas.1802977115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition
- (2017) O. B. Suhr et al. JOURNAL OF INTERNAL MEDICINE
- Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel
- (2017) Guglielmo Verona et al. Scientific Reports
- Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines
- (2016) Jean D. Sipe et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study
- (2016) Violaine Planté-Bordeneuve et al. JOURNAL OF NEUROLOGY
- Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
- (2016) Ricardo Sant'Anna et al. Nature Communications
- A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis
- (2015) J. Marcoux et al. EMBO Molecular Medicine
- Uncovering the Mechanism of Aggregation of Human Transthyretin
- (2015) Lorena Saelices et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Repurposing Diflunisal for Familial Amyloid Polyneuropathy
- (2015) John L. Berk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quantification of Quaternary Structure Stability in Aggregation-Prone Proteins under Physiological Conditions: The Transthyretin Case
- (2014) Lei Z. Robinson et al. BIOCHEMISTRY
- Online Registry for Mutations in Hereditary Amyloidosis Including Nomenclature Recommendations
- (2014) Dorota M. Rowczenio et al. HUMAN MUTATION
- PASTA 2.0: an improved server for protein aggregation prediction
- (2014) Ian Walsh et al. NUCLEIC ACIDS RESEARCH
- Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis
- (2014) P. P. Mangione et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis
- (2013) Elisabet Ihse et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
- (2013) Teresa Coelho et al. JOURNAL OF NEUROLOGY
- Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
- (2012) C. E. Bulawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum transthyretin levels in Swedish TTR V30M carriers
- (2010) Joel Buxbaum et al. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
- Protein kinetic stability
- (2010) Jose M. Sanchez-Ruiz BIOPHYSICAL CHEMISTRY
- Trapping of palindromic ligands within native transthyretin prevents amyloid formation
- (2010) S. E. Kolstoe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantification of the Thermodynamically Linked Quaternary and Tertiary Structural Stabilities of Transthyretin and Its Disease-Associated Variants: The Relationship between Stability and Amyloidosis†
- (2008) Amy R. Hurshman Babbes et al. BIOCHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started